Fig. 7From: Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarkerIdentification of serum ANGPTL6 as a sensitive biomarker for HCC. ANGPTL6 and AFP protein level (a) and mRNA level (b) in plasma or serum. ROC curve of serum ANGPTL6, AFP alone or combination of ANGPTL6 and AFP for diagnosis of HCCÂ in our validation set (c) and GEO database (d)Back to article page